Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Knigge

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PETTina Binderup, Ulrich Knigge, Annika Loft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2016
Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 PatientsCamilla B Johnbeck, Ulrich Knigge, Seppo W Langer, et al.
Journal of Surgical Case Reports|June 3, 2024
Successful liver transplantation as rescue therapy in a patient with metastases from a vasoactive intestinal peptide producing neuroendocrine tumorMikkel Andreassen, Rajendra Singh Garbyal, Peter Nørgaard Larsen, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 2015
Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the artElizaveta Mitkina Tabaksblat, Seppo W Langer, Ulrich Knigge, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PETMathias Loft, Camilla B Johnbeck, Esben A Carlsen, et al.
Diagnostics (Basel, Switzerland)|January 30, 2016
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine TumorYin Wu, Andreas Klaus Pfeifer, Rebecca Myschetzky, et al.
Surgical Oncology|March 1, 2022
Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinomaPatrick Soldath, Tina Binderup, Frederik Carstensen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive ScansEsben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, et al.
Cancers|February 10, 2024
Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical CarcinoidsPatrick Soldath, Daniel Bianchi, Beatrice Manfredini, et al.
Genes|July 6, 2018
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine CellsKristina B V Døssing, Christina Kjær, Jonas Vikeså, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PETTina Binderup, Ulrich Knigge, Annika Loft, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2016
Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 PatientsCamilla B Johnbeck, Ulrich Knigge, Seppo W Langer, et al.
Journal of Surgical Case Reports|June 3, 2024
Successful liver transplantation as rescue therapy in a patient with metastases from a vasoactive intestinal peptide producing neuroendocrine tumorMikkel Andreassen, Rajendra Singh Garbyal, Peter Nørgaard Larsen, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 2015
Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the artElizaveta Mitkina Tabaksblat, Seppo W Langer, Ulrich Knigge, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PETMathias Loft, Camilla B Johnbeck, Esben A Carlsen, et al.
Diagnostics (Basel, Switzerland)|January 30, 2016
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine TumorYin Wu, Andreas Klaus Pfeifer, Rebecca Myschetzky, et al.
Surgical Oncology|March 1, 2022
Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinomaPatrick Soldath, Tina Binderup, Frederik Carstensen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive ScansEsben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, et al.
Cancers|February 10, 2024
Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical CarcinoidsPatrick Soldath, Daniel Bianchi, Beatrice Manfredini, et al.
Genes|July 6, 2018
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine CellsKristina B V Døssing, Christina Kjær, Jonas Vikeså, et al.
Pageof 11